Current Investments

CATO Research (“CATO”) is a global provider of regulatory, compliance, and Contract Research Organization (CRO) services. CATO offers a range of services including regulatory strategy and submissions, project management, medical writing, biostatistics, data management, pharmacokinetics, pharmacovigilance, quality assurance, and trial management.  CATO has completed more than 400 trials across all phases to achieve a strong track record of product approvals on behalf of its biopharmaceutical clients.  In 2019, JLL Partners acquired THREAD, an innovative provider of technology that enables virtual research approaches to modernize clinical studies and registries. THREAD’s platform and services are designed to make clinical research more accessible and less costly by replacing patient visits at investigator sites with technology-enabled interactions at more convenient locations, including patients’ homes. CATO will engage THREAD on opportunities where its unique platform of capabilities will benefit its clients.

INVESTMENT STRATEGY

Growing and Attractive Industry: The compliance and regulatory services market benefits from favorable tailwinds which include consistent growth in R&D spend, a large and growing pipeline of specialty pharmaceuticals, and increasing use of outsourced compliance and regulatory services.

‚Äč

Established Platform for Scale:  Through strategic add-on acquisitions and identified organic growth initiatives, JLL seeks to transform CATO into a premier global clinical and regulatory services partner to pharmaceutical companies.


Visit CATO Research